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ABSTRACTS   
The intrinsic factors that caused aging are enzymes such as hyaluronidase and elastase by oxidative stress mechanism. Antioxidants are the 
bioactive compounds which are highly important to fight against oxidative stress that can cause aging. Modified compounds of apigenin have 
reported can act as an antioxidant. The aim of this study was to determine candidate of apigenin derivative compounds that were potential to 
inhibit hyaluronidase and elastase enzyme by using molecular docking method with human target protein with pdb.id : 2JIE and 5JMY. 
Molecular docking was done using windows operating system with several softwares, i.e: PLANTS, YASARA and MarVinSketch. 
Visualization of bonding modes between the ligand and amino acid residues was done with PyMol. Of the 50 apigenin derivative compounds 
tested, obtained 9 compounds with lower docking scores than apigenin in inhibiting hyaluronidase and 5 compounds in inhibiting elastase 
enzyme. 3’6-diamineapigenin had the lowest docking score (-62.39) in inhibiting hyaluronidase enzyme (2JIE) and 3’amineapigenin had the 
lowest docking score (-91.31) in inhibiting elastase enzyme (5JMY). The binding interactions of the actively docked conformations of the ligand 
and the target protein have been identified and showed the most amino acid residues that considered affect hyaluronidase and elastase inhibition 
process such as VAL_710, GLU_762 and VAL_763. Based on these results, there are some antioxidants of the apigenin derivative compounds 
that recommended as an anti-aging agent.  
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1. Introduction 
Aging is a process of gradual disappearance of the 
network's ability to repair or replace itself and maintain its 
structure, as well as its normal function. Skin can experience 
aging, one of which is marked by the emergence of wrinkles 
(wrinkle). It does not occur solely because of the increasing 
age of the skin itself, but can also occur due to external factors. 
Aging can also be caused by various factors, i.e factors that 
come from within the body itself (intrinsic factor) or factors 
that come from outside body (extrinsic factor). The intrinsic 
factors include the activity of certain enzymes. Increased 
activity of certain enzymes involved in the aging process of the 
skin includes elastase, hyaluronidase, and collagenase (Thring 
et al., 2009). 
Elastase is a proteolytic enzyme involved in the 
degradation of the extracellular matrix (ECM) that includes 
elastin. Elastin provides much of the elastic recoil properties of 
skin, arteries, lungs, and ligaments. Loss of elastin is a major 
part of what causes visible signs of aging (wrinkles, sagging) 
in the skin (Thring et al., 2009). 
Hyaluronic acid or hyaluronan is one of the important 
components of the tissue matrix substance and has a role in the 
development, growth, and repair of damaged tissue (Pogrel et 
al., 1996). Meanwhile, elastin plays a role in the maintenance 
of skin elasticity, but elastase can degrade it (Thring et al., 
2009). Degradation of the Extracellular Matrix (ECM) has 
been directly linked to skin aging and is correlated with an 
increase in activity of certain enzymes involved in skin aging 
(Longo et al., 2003; Makrantonaki et al., 2010). Inhibition of 
these enzymes is crucial in anti-aging prevention (Ndlovu et 
al., 2013). 
 
Fig. 1. Based structure of apigenin 
Apigenin is the main organic compound of flavonoids 
contained in celery belonging to the flavon group (Fig.1). The 
compound that has three aromatic rings with the -OH- grouped 
branches. Apigenin can be synthesized and developed into a 
potent antioxidant compound (Seyoum et al., 2006; Ray, 
2012). Several studies related to the development of apigenin 
structure have been done to increase the ability of antioxidant 
activity (Perwira et al., 2015; Mumpuni et al., 2017). Mumpuni 
et al. (2017) has modified the structure of the apigenin and 
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predicted its ability as antioxidant using the QSAR method 
(Semiempirical Austin Model 1). Of the 90 modified 
compounds of apigenin, obtained 50 compounds that have 
better activity as antioxidant than apigenin.  
Antioxidants are the bioactive compounds which are 
highly important to fight oxidative stress that can produce free 
radicals which are affected for various diseases such as heart 
attack, cancer, cataract, atherosclerosis, neurodege-nerative 
disease, decreased kidney function, diabetes, and premature 
aging (Uttara et al., 2009).     
 
Fig.2. Crystalline Structure of Receptor (A) 2JIE; (B) 5JMY 
(http://rcsb.org)  
In this study carried out analysis of apigenin 
derivative compounds that have been reported by Mumpuni et 
al. (2017) as an antioxidant that plays a role in inhibition of 
hyaluronidase and elastase enzyme using molecular docking 
method with enzyme of hyaluronidase and elastase that present 
in protein data bank (PDB) data base with id 2JIE and 5JMY 
(Fig. 2). Visualization and elucidation of the bonding mode 
between a ligand and target protein to determine amino acids 
residues that play a role in ligand-protein affinity in the 
inhibition process. In this study will also be screened about the 
toxicity of apigenin derivative compounds using a protox 
webserver.  
2. Materials and Methods 
2.1. Tools. 
The hardware used in this research is a laptop with 
AMD A6 processor, 4 GB RAM, Windows 10, 64-bit 
operating system. Software used includes: PLANTS, Marvin 
Skecth, PyMol, and YASARA.   
2.2. Materials 
Fifteen (50) 2D structures of apigenin derivative 
compounds of research results by Mumpuni et al. (2017), 
crystalline form of protein with PDB ID : 5JMY and 2JIE. 
 2.3. Research Procedure 
2.3.1. Preparation of Proteins and Ligands 
Preparation of proteins and ligands was done using 
YASARA software. Proteins with 5JMY.pdb.id and 
2JIE.pdb.id that have been downloaded from database of 
Protein Data Bank loaded on YASARA worksheets, proteins, 
and native ligands are separated and saved with file names 
protein.mol2 and ref_ligand.mol2. Native ligands and new 
ligands (apigenin derivative compounds) are continuously 
prepared to form conformations using Marvin Skecth and 
saved with file name ligand.mol2. 
2.3.2. Docking protocol validation 
The docking protocol validation is performed by 
calculating the Root Mean Square Deviation (RMSD) values 
between the native ligand of pdb.id with the conformation of 
the docked ligand. Docking protocol is considered good and 
can be used for the further docking process if it has a value of 
2 - 2.5 Å, closer to 0 considered the alignment is better. This 
validation result used to configure the plantsconfig.file.  
2.3.2. Molecular docking 
The docking process has done with standard procedure 
of molecular docking using PLANTS (Korb et al., 2009; 
Purnomo, 2010). Validated protocol (plantsconfig.file), 
ref_ligand.mol2, protein.mol2, and ligand.mol2 prepared as 
input data. Docking process has done by typing commands on 
cmd. The PLANTS application will read the validated protocol 
and start the docking process. Docking process obtained 
docking scores as output data that showed the energy of the 
ligand in binding to the target protein. The more negative of 
docking scores the affinity of the ligand binding to the protein 
is stronger.  
2.3.2. Toxicity Screening   
Toxicity screening has done using ProTox webserver, 
test compounds were prepared with SMILES file type. Then 
input on ProTox webserver then run the calculating program of 
toxicity. The toxicity level performed in LD50, mg/kg unit. 
3. Results and Discussion 
The RMSD value obtained from the docking protocol 
validation process was 1.1 Å for 5JMY enzyme and 1.69 Å for 
the 2JIE enzyme, this value is eligible for the protocol to be 
used for further docking process. The alignment between the 
reference ligand and the conformation of the docked ligand is 
very good (Fig. 3). The docking process of apigenin derivative 
compounds was performed on 50 apigenin derivative 
compounds that were tested in silico by QSAR method that 
having better antioxidant activity than apigenin by Mumpuni et 
al. (2017) (Table 1). Of the 50 compounds tested, obtained 9 
compounds having a lower docking score than apigenin in 
inhibiting hyaluronidase enzyme i.e 3,6-diethoxy apigenin, 3'-
amine apigenin, 3,6-dimethoxy apigenin, 3,6-dipropoxy 
apigenin, 3’-ethoxy apigenin, 3’- fluoro apigenin, 3'6  diamine  
apigenin,  6-amine    apigenin, 6-methyl-apigenin and 5 
compounds that having a lower docking score than apigenin in 
inhibiting elastase enzyme i.e 3’-amine apigenin, 3,3’-
dimethyl apigenin, 3,3’-dipropyl apigenin, 3’- fluoro apigenin, 
3'6-diamine apigenin. The 3’6-diamine apigenin had the lowest 
docking score in inhibiting hyaluronidase enzyme (2JIE) and 
the 3’amineapigenin had the lowest docking score in inhibiting 
elastase enzyme (5JMY). The chemical structures of these 
compounds are shown in Fig. 4.   Through   molecular 
 
Fig. 3. Alignment of ref_ligand (red) of (A) 2JIE and (B) 5JMY 
receptor with docked ligand conformation (yellow) 
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Table 1. Docking score of apigenin derivative compounds 
 
apigenin derivative compo-
unds (test ligand) 
Receptor 
LD50 (mg/Kg) No Hyaluronidase 
(2JIE) 
Elastase 
(5JMY) 
1.  3 3'6 trimethoxy apigenin -49.64 -57.80 5000 
2.  3 6 diethoxy apigenin -57.40 -76.31 5000 
3.  3' amine apigenin -57.58 -91.31 3919 
4.  3 amine apigenin -49.21 -72.05 3919 
5.  3 ethoxy apigenin -48.08 -77.21 5000 
6.  3 ethyl apigenin -51.23 -77.71 3919 
7.  3- isopropyl apigenin -51.15 -72.96 3919 
8.  3 isopropoxy apigenin -49.08 -73.14 3919 
9.  3- methyl apigenin -52.48 -73.7 3919 
10.  3- methoxy apigenin -52.47 -79.98 3919 
11.  3- propyl apigenin -51.27 -82.29 3919 
12.  3 propoxy apigenin -46.30 -75.31 5000 
13.  3,3’,6-triethyl apigenin -47.74 -75.51 159 
14.  3,3’,6-triethoxy apigenin -44.73 -59.77 5000 
15.  3,3’,6-triisopropyl apigenin -51.25 -73.18 159  
16.  3,3’,6-triisopropoxy apigenin -42.65 -72.59 5000 
17.  3,3’,6-trimethyl apigenin -50.66 -75.81 159 
18.  3,3’,6-tripropyl apigenin -48.08 -70.90 159 
19.  3,3’,6-tripropoxy apigenin -47.95 -62.57 5000 
20.  3,3’-diethyl apigenin -48.85 -80.59 159 
21.  3,3’-diisopropyl apigenin -51.15 -73.94 159 
22.  3,3’-dimethyl apigenin -50.79 -86.94 3919 
23.  3,3’-dipropyl apigenin -52.78 -87.74 159 
24.  3,3’-dipropoxy apigenin -50.38 -71.62 5000 
25.  3,6-diisopropyl apigenin -50.37 -69.35 159 
26.  3,6-dimethyl apigenin -50.02 -77.24 159 
27.  3,6-dimethoxy apigenin -58.83 -82.98 5000 
28.  3,6-dipropyl apigenin -49.60 -75.58 159 
29.  3,6-dipropoxy apigenin -58.83 -82.97 5000 
30.  3’- ethoxy apigenin -58.85 -82.97 4000 
31.  3’- fluoro apigenin -57.44 -86.97 3919 
32.  3’- chloro apigenin -55.88 -81.80 1070 
33.  3’,6-diethoxy apigenin -53.82 -83.14 3919 
34.  3’,6-dimethoxy apigenin -48.85 -83.29 3919 
35.  3’,6-dipropoxy apigenin -53.83 -83.28 5000 
36.  3'6 diamine apigenin -62.39 -85.21 1070 
37.  6-amineapigenin -57.14 -83.65 1070 
38.  6-ethyl-apigenin -55.81 -80.17 3919 
39.  6-ethoxy apigenin -53.88 -80.73 4000 
40.  6-propoxy-apigenin -49.39 -75.75 4000 
41.  6-methyl-apigenin -56.71 -78.86 3919 
42.  6-methoxy apigenin -50.83 -75.72 4000 
43.  33’ diamine apigenin -50.76 -76.02 3919 
44.  33’ diethoxy apigenin -51.53 -74.58 5000 
45.  33’ diisopropoxy apigenin -51.05 -74.49 159 
46.  33’ dimethoxy apigenin -51.19 -74.49 5000 
47.  33’6 triamine apigenin -53.63 -74.39 3919 
48.  36 diamine apigenin -48.16 -67.84 3919 
49.  36 diethyl apigenin -51.56 -72.07 159 
50.  36 diisopropoxy apigenin -50.34 -68.79 159 
51.  Apigenin  -56.15 -84.80 2500 
can be known the potential of compounds to be a drug 
candidates based on the affinity of binding to target proteins 
(Kastritis et al., 2012). Binding affinity is an important aspect 
to be considered in molecular and macro molecular 
interactions (Seo et al., 2014). This binding affinity was                       
illustrated by the value of the docking score. Lower binding 
affinities indicate that a compound requires less energy to 
engage in binding or interaction. In other words, the lower 
affinity value of binding increases the potential for binding to 
the target protein (Baker et al., 2007; Tassa et al., 2010). Score 
docking of 3’6 diamine apigenin and 3’amine apigenin were -
62.39 and -91.31 (Table 1). These were the lowest score than 
the others derived compounds of apigenin. Its considered that 
3’6 diamine apigenin and 3’amine apigenin have the best 
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Fig.4. Structure of (A) 3’6-diamine apigenin (B) 3’amine apigenin 
affinity in the binding site of anti-aging receptor 2JIE and  
5JMY respectively. The negative value of binding energy 
change (ΔG) reveals that the binding process is spontaneous, it 
can fit well in the binding pocket receptor forming most stable 
drug receptor energetically (Kumar et al., 2014). Larger the 
negative value of binding energy, greater the chemical be 
accepted as a drug (Balavignesh et al., 2013).  
 
Fig.5. Hydrophobic areas (green) and hydrogen bond mapping 
(purple) in binding pocket of ligand-receptor (A) apigenin – 2JIE (B) 
apigenin – 5JMY (C) 3’6-diamine apigenin – 2JIE (D) 3’ amine 
apigenin – 5JMY 
The better affinity was due to the replacement of 
substituent affecting the properties of the ligand, based on the 
receptor properties mapping showed in Fig. 5. It was seen that 
the binding pocket of the 5JMY receptor was more 
hydrophobic than the binding pocket of the 2JIE receptor 
(green). The substitution of hydrogen had an effect on the 
lipophilicity of ligand, replacing H atom with an amine group 
at position 3’ have made the log P value of 3'amine apigenin 
(2.002) not much different from apigenin (2.1). A large log P 
value makes 3'amine apigenin had a good interaction in 
binding pocket of the 5JMY receptor. Whereas replacement of 
hydrogen with amine groups at positions 3' and 6 on apigenin 
actually decreases the log P value of 3'6-diamine apigenin 
(1.5). It makes the hydrophobicity of 3'6-diamine apigenin was 
lower than api-genin. 3'6-diamine apigenin had a better affinity 
in the bind-ing pocket of the 2JIE receptor. The log P value 
could be used to show the ability of a molecule to penetrate a 
biological membrane that was like a fat layer (Hansch et al., 
1972).  
 
Fig. 6. Hydrogen bond (red) and Van Der Walls interaction (blue) of 
ligand and active amino acid residues of the receptor (A) apigenin – 
2JIE (B) apigenin – 5JMY (C) 3’6-diamine apigenin – 2JIE (D) 3’ 
amine  apigenin – 5JMY 
The binding interactions of the most active docked 
conformation of the ligands of apigenin derivative compound 
and the target proteins have been identified using PyMol. 
Checked one by one all amino acids within 4 Å of the active 
site of the target protein, the important binding interactions 
were identified. The interaction of ligands with the binding 
pocket receptor is shown in Fig. 3. Apigenin and 3’ amine 
apigenin occupied the same binding pocket of the 5JMY 
receptor with some active amino acid residues i.e THR_708, 
ASP_709, HIS_711, ARG_222, VAL_710, ARG_102. 
ARG_110, ASN_542, PHE_544. Hydrogen bonds formed 
between apigenin and active amino acid residue ASP_709 and 
VAL_710 with distances 1.89 and 2.1 Å respectively, whereas 
in 3'amine apigenin formed a hydrogen bond with active 
amino acid residue VAL_710 with distance 3.23 Å (Fig. 6).  
Apigenin and 3’6-diamine a pigenin occupied the same 
binding pocket of 2JIE receptor with some active amino acid 
residues i.e LUE_672, THR_673, HIS_671, SER_634, 
ALA_633, THR_632, ILE_631, ALA_645, TRP_657, 
ALA_648, ALA_760, GLU_762, VAL_763, ALA_688, 
TYR_687, LYS_727, LEU_720, TYR_701, ILE_698, 
VAL_743, and LEU_741. Apigenin formed Van Der Walls 
interactions with active amino acid residue HIS_671 and 
LEU_672 with distance 2.17 Å and 1.62 Å, whereas 3’6-
diamine apigenin forming a hydrogen bond with active amino 
acid residue GLU_762 with distance 0.74 Å and formed a Van 
Der Walls interaction with active amino acid residue 
VAL_763 with distance 1.97 Å. In addition to hydrogen 
bonding, the activity of ligand inhibiting on receptor was also 
influenced by electronic bonding, hydrophobic and van der 
walls interaction (Khalid et al., 2013).  
Toxicity of compounds is very important on 
determining a candidate of a drug. So, in this research has 
done tested the toxicity of apigenin derivative compounds 
(Table 1). The most apigenin derivative compounds have very 
low toxicity, included the both of active compounds i.e 3’6-
diamine apigenin and 3’amine apigenin. 
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4. Conclusion  
The most active conformation of apigenin derivative 
compound as antioxidant acting as anti-aging agent is the 3’6-
diamine apigenin that active to inhibit hyaluronidase enzyme 
(2JIE) and the 3’amine apigenin that active to inhibit elastase 
enzyme (5JMY).     
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